Healthcare

Lack of accessible monkeypox testing threatens response to outbreaks

By Cassidy Morrison
Published May 27, 2022 9:00am ET
Add Washington Examiner on Google
Lack of accessible monkeypox testing threatens response to outbreaks
The absence of accessible testing for monkeypox threatens an effective early response to the outbreak. The United States does not make PCR diagnostic tests for monkeypox commercially available, which could make early efforts to forestall an outbreak impossible. The U.S. has already been caught unawares when it comes to testing for COVID-19, and it took […]


The absence of accessible testing for monkeypox threatens an effective early response to the outbreak.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Centers for Disease Control and Prevention COVID-19 FDA Rochelle Walensky Scott Gottlieb Zika Virus